| scholarly article | Q13442814 |
| P2093 | author name string | Juan Lin | |
| Jun Fang | |||
| Zhun Wang | |||
| Zhimin Ye | |||
| Yaping Xu | |||
| Yuezhen Wang | |||
| Qingren Lin | |||
| Maohui Yan | |||
| Feiying Gu | |||
| P2860 | cites work | The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage | Q22010200 |
| Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells | Q24680095 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Histone H2A variants H2AX and H2AZ | Q28207014 | ||
| Genomic instability in mice lacking histone H2AX | Q28589826 | ||
| A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer | Q33360400 | ||
| Phase II trial of combination chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced cancers of the bile duct, gallbladder, and ampulla of Vater | Q33408252 | ||
| TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system | Q33705275 | ||
| Molecular mechanisms involved in cisplatin cytotoxicity. | Q34058522 | ||
| DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance | Q34067050 | ||
| Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma | Q34159084 | ||
| Mechanisms of resistance to cisplatin | Q34282241 | ||
| Epidemiology and molecular pathology of gallbladder cancer | Q34473041 | ||
| Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK | Q35751980 | ||
| Chemoresistance in non-small cell lung cancer | Q36048311 | ||
| DNA damage-induced cell death by apoptosis. | Q36561337 | ||
| Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells | Q37112491 | ||
| Mechanism of elimination of phosphorylated histone H2AX from chromatin after repair of DNA double-strand breaks | Q37580072 | ||
| Enhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies | Q37687673 | ||
| DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis | Q37977244 | ||
| Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells | Q38291790 | ||
| DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine | Q39035732 | ||
| Nuclear translocation of MRP1 contributes to multidrug resistance of mucoepidermoid carcinoma | Q39477047 | ||
| MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer | Q39833753 | ||
| DUSP1 is controlled by p53 during the cellular response to oxidative stress | Q39993123 | ||
| Dual specificity phosphatase 1/CL100 is a direct transcriptional target of E2F-1 in the apoptotic response to oxidative stress | Q40105528 | ||
| Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance | Q40136474 | ||
| Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK. | Q40388836 | ||
| Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. | Q40550067 | ||
| Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells | Q40664009 | ||
| Insights into mechanisms of cisplatin resistance and potential for its clinical reversal | Q41028725 | ||
| High level of mitogen-activated protein kinase phosphatase-1 expression is associated with cisplatin resistance in osteosarcoma | Q41882645 | ||
| Gemcitabine-based adjuvant chemotherapy for patients with advanced gallbladder cancer | Q44250257 | ||
| Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer | Q44346549 | ||
| Gemcitabine and Cisplatin Is a Highly Effective Combination Chemotherapy in Patients With Advanced Cancer of the Gallbladder | Q44417559 | ||
| Role of the p38 MAPK pathway in cisplatin-based therapy | Q44488190 | ||
| Infusion chemotherapy with cisplatinum and fluorouracil in the treatment of locally-advanced and metastatic gallbladder cancer | Q46217328 | ||
| HIF1 regulates WSB-1 expression to promote hypoxia-induced chemoresistance in hepatocellular carcinoma cells | Q46246530 | ||
| AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance | Q47971254 | ||
| Assessing the satisfaction and burden within an academic animal care and use program. | Q50640144 | ||
| Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. | Q53431175 | ||
| Structure, Recognition, and Processing of Cisplatin-DNA Adducts. | Q55035583 | ||
| Gallbladder cancer | Q57646726 | ||
| CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin | Q73155209 | ||
| Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study | Q73597526 | ||
| Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer | Q73707393 | ||
| P433 | issue | 2 | |
| P921 | main subject | gallbladder cancer | Q977787 |
| P304 | page(s) | 1869-1875 | |
| P577 | publication date | 2018-05-29 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | DUSP1 enhances the chemoresistance of gallbladder cancer via the modulation of the p38 pathway and DNA damage/repair system | |
| P478 | volume | 16 |
| Q92015325 | Identification and interaction analysis of key miRNAs in medullary thyroid carcinoma by bioinformatics analysis | cites work | P2860 |
Search more.